Greenhalf W - Search Results

1

ABO blood groups and pancreatic cancer risk and survival: results from the PANcreatic Disease ReseArch (PANDoRA) consortium.

Rizzato C, Campa D, Pezzilli R, Soucek P, Greenhalf W, Capurso G, Talar-Wojnarowska R, Heller A, Jamroziak K, Khaw KT, Key TJ, Bambi F, Landi S, Mohelnikova-Duchonova B, Vodickova L, Büchler MW, Bugert P, Vodicka P, Neoptolemos JP, Werner J, Hoheisel JD, Bauer AS, Giese N, Canzian F. Rizzato C, et al. Among authors: greenhalf w. Oncol Rep. 2013 Apr;29(4):1637-44. doi: 10.3892/or.2013.2285. Epub 2013 Feb 12. Oncol Rep. 2013. PMID: 23403949

2

The potential for gene therapy in pancreatic cancer.

Humphreys MJ, Greenhalf W, Neoptolemos JP, Ghaneh P. Humphreys MJ, et al. Among authors: greenhalf w. Int J Pancreatol. 1999 Aug;26(1):5-21. doi: 10.1385/IJGC:26:1:5. Int J Pancreatol. 1999. PMID: 10566154 Review.

3

Screening for early pancreatic ductal adenocarcinoma in hereditary pancreatitis.

Howes N, Greenhalf W, Neoptolemos J. Howes N, et al. Among authors: greenhalf w. Med Clin North Am. 2000 May;84(3):719-38, xii. doi: 10.1016/s0025-7125(05)70254-6. Med Clin North Am. 2000. PMID: 10872428 Review.

4

Molecular pathogenesis of pancreatic ductal adenocarcinoma and clinical implications.

Magee CJ, Greenhalf W, Howes N, Ghaneh P, Neoptolemos JP. Magee CJ, et al. Among authors: greenhalf w. Surg Oncol. 2001 Jul-Aug;10(1-2):1-23. doi: 10.1016/s0960-7404(01)00016-0. Surg Oncol. 2001. PMID: 11719025 Review.

5

Detailed tissue expression of bcl-2, bax, bak and bcl-x in the normal human pancreas and in chronic pancreatitis, ampullary and pancreatic ductal adenocarcinomas.

Evans JD, Cornford PA, Dodson A, Greenhalf W, Foster CS, Neoptolemos JP. Evans JD, et al. Among authors: greenhalf w. Pancreatology. 2001;1(3):254-62. doi: 10.1159/000055820. Pancreatology. 2001. PMID: 12120204

6

Molecular diagnosis of early pancreatic ductal adenocarcinoma in high-risk patients.

Wong T, Howes N, Threadgold J, Smart HL, Lombard MG, Gilmore I, Sutton R, Greenhalf W, Ellis I, Neoptolemos JP. Wong T, et al. Among authors: greenhalf w. Pancreatology. 2001;1(5):486-509. doi: 10.1159/000055852. Pancreatology. 2001. PMID: 12120229 Review.

7

5-Fluorouracil or gemcitabine combined with adenoviral-mediated reintroduction of p16INK4A greatly enhanced cytotoxicity in Panc-1 pancreatic adenocarcinoma cells.

Halloran CM, Ghaneh P, Shore S, Greenhalf W, Zumstein L, Wilson D, Neoptolemos JP, Costello E. Halloran CM, et al. Among authors: greenhalf w. J Gene Med. 2004 May;6(5):514-25. doi: 10.1002/jgm.540. J Gene Med. 2004. PMID: 15133762

8

No evidence for germline mutations of the LKB1/STK11 gene in familial pancreatic carcinoma.

Grützmann R, McFaul C, Bartsch DK, Sina-Frey M, Rieder H, Koch R, McCarthy E, Greenhalf W, Neoptolemos JP, Saeger HD, Pilarsky C. Grützmann R, et al. Among authors: greenhalf w. Cancer Lett. 2004 Oct 8;214(1):63-8. doi: 10.1016/j.canlet.2004.06.012. Cancer Lett. 2004. PMID: 15331174

9

Cationic trypsinogen mutations and pancreatitis.

Howes N, Greenhalf W, Stocken DD, Neoptolemos JP. Howes N, et al. Among authors: greenhalf w. Gastroenterol Clin North Am. 2004 Dec;33(4):767-87. doi: 10.1016/j.gtc.2004.07.003. Gastroenterol Clin North Am. 2004. PMID: 15528017 Review.

10

Cationic trypsinogen mutations and pancreatitis.

Howes N, Greenhalf W, Stocken DD, Neoptolemos JP. Howes N, et al. Among authors: greenhalf w. Clin Lab Med. 2005 Mar;25(1):39-59. doi: 10.1016/j.cll.2004.12.004. Clin Lab Med. 2005. PMID: 15749231 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

211 results

Search Page